Nathan K. LeBrasseur
Physiology · 2010–2021
A researcher in the Science corpus: 10 papers; trusts 3 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Physiology — 115 citations into it; #1,024 of 2,276 by trust here, #157 by citations
Whom Nathan K. LeBrasseur trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- T. Tchkonia (in Physiology)
- J. Kirkland (in Physiology)
- J. Campisi (in Physiology)
Who trusts Nathan K. LeBrasseur
- J. Kirkland (in Physiology)
- T. Tchkonia (in Physiology)
- J. Campisi (in Physiology)
Papers from Nathan K. LeBrasseur's perspective
Ordered by how strongly the researchers Nathan K. LeBrasseur trusts endorse each paper. Same corpus, a different order for every researcher.
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas (Nature)
- Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders (Nature)
- Senescence of activated stellate cells limits liver fibrosis (Cell)
- Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence (Nature Cell Biology)
- Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis (Psychosomatic Medicine)
- Blinded by the Light: The Growing Complexity of p53. (Cell)
- Removing technical variability in RNA-seq data using conditional quantile normalization (Biostatistics)
- Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). (American Journal of Physiology. Heart and Circulatory Physiology)
- Cellular senescence mediates fibrotic pulmonary disease (Nature Communications)
- DNA damage response and cellular senescence in tissues of aging mice (Aging Cell)
Their papers
- Adverse Events Associated with Testosterone Administration (2010) — 1,293 citations
- A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues (2021) — 803 citations
- Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease (2019) — 1,153 citations
- Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study (2019) — 1,080 citations
- Senolytics Improve Physical Function and Increase Lifespan in Old Age (2018) — 1,970 citations
- Targeting cellular senescence prevents age-related bone loss in mice (2017) — 1,011 citations
- Cellular senescence mediates fibrotic pulmonary disease (2017) — 1,412 citations
- The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs (2015) — 2,184 citations
- JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age (2015) — 792 citations
- Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders (2011) — 3,430 citations